Skip to main content

Advertisement

SpringerLink
Log in

Axillary surgery for breast cancer: past, present, and future

  • Review Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

In breast cancer surgery, there has been a major shift toward less invasive local treatment. Although axillary lymph node dissection (ALND) was an integral part of surgical treatment for breast cancer, sentinel lymph node (SLN) biopsy was developed as an accurate method for axillary staging. ALND can be avoided not only in patients with negative SLNs but also in those with one or two positive SLNs receiving breast and/or axillary radiation. On the other hand, ALND has remained the standard treatment for patients with clinically positive nodes. However, axillary reverse mapping (ARM) was developed to map and preserve arm lymphatic drainage during ALND and/or SLN biopsy. This procedure allowed reduction of the rate of arm lymphedema without increasing axillary recurrence, although patients receive postoperative chemotherapy and high-risk patients undergo axillary radiation. Standard ALND may not be necessary even for patients with clinically positive nodes who receive axillary radiation and systemic therapy. Thus, the extent of axillary surgery in breast cancer has been decreased with increased use of systemic and radiation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Halsted WS. The results of radical operation for the cure of carcinoma of the breast. Ann Surg. 1907;46:1–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75.

    Article  PubMed  Google Scholar 

  3. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat. 1995;5:17–211.

    Article  Google Scholar 

  4. Hellman S, Harris JR. Natural history of breast cancer. In: Harris JR, editor. Disease of the breast. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 407–423.

    Google Scholar 

  5. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg. 1984;119(9):1067–72.

    Article  CAS  PubMed  Google Scholar 

  6. Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka H, et al. The role of axillary lymph node dissection in breast cancer management. Breast Cancer. 1997;4:143–53.

    Article  CAS  PubMed  Google Scholar 

  7. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.

    Article  CAS  PubMed  Google Scholar 

  8. Krag DN, Weaver DL, Alex LC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335–9.

    Article  CAS  PubMed  Google Scholar 

  9. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–66.

    Article  CAS  PubMed  Google Scholar 

  11. Noguchi M. Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection? Breast Cancer. 2003;10:179–87.

    Article  PubMed  Google Scholar 

  12. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251:595–600.

    Article  PubMed  Google Scholar 

  14. Noguchi M, Tsugawa K, Kawahara F, Bando E, Miwa K, Minato H, et al. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients. Breast Cancer. 1998;5:381–7.

    Article  CAS  PubMed  Google Scholar 

  15. Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, et al. A multicenter validation study of sentinel lymph node biopsy can replace routine axillary dissection? Breast Cancer. 2000;63:31–40.

    CAS  Google Scholar 

  16. Nakamura S, Tsugawa K, Iwata H, Ohno S, Akiyama F, Motomura K, et al. A multicenter-based phase II study on the safety of sentinel lymph node biopsy for primary breast cancer without clinical axillary lymph node metastases. Jpn J Breast Cancer. 2009;24(2):271–7 (in Japanese with English abstract).

    Google Scholar 

  17. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastases: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918–26.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Morrow M. It is not always necessary to do axillary dissection for T1 and T2 breast cancer. Cancer Res. 2013;73:7151–4.

    Article  CAS  PubMed  Google Scholar 

  19. Beek MA, Verheuvel NC, Luiten EJT, Klompenhouwer EG, Rutten HJT, Roumen RMH, et al. Two decades of axillary management in breast cancer. BJS. 2015;102:1658–64.

    Article  CAS  Google Scholar 

  20. Galimberti V, Cole BF, Viale G, Veronesi P, Vicini E, Intra M, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23–1): 10-year follow-up of a randomised, controlled, phase 3 trial. Lancet Oncol. 2018;19:1385–93.

    Article  PubMed  Google Scholar 

  21. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981–22023 AMAROS): a randomized multicenter, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303–10.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Savolt A, Peley G, Polgar C, Udvarhelyi N, Rubovszky G, Kovacs E, et al. Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla -surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672–9.

    Article  CAS  PubMed  Google Scholar 

  23. Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). The Breast. 2012;21:678–81.

    Article  PubMed  Google Scholar 

  24. Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, et al. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol. 2007;14(6):l1800–1805.

    Article  Google Scholar 

  25. Nos C, Lesieur B, Clough KB, Lecuru F. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol. 2007;14(9):2490–6.

    Article  PubMed  Google Scholar 

  26. Klimberg VS. A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Ocol. 2008;97(7):563–4.

    Google Scholar 

  27. Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer. J Surg Oncol. 2010;101(3):217–21.

    Article  PubMed  Google Scholar 

  28. Noguchi M, Noguchi M, Ohno Y, Morioka E, Nakano Y, Kosaka T, et al. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer. Eur J Surg Oncol. 2016;42:650–6.

    Article  CAS  PubMed  Google Scholar 

  29. Noguchi M, Miura S, Morioka E, Ohno Y, Yokoi-Noguchi M, Nakano Y, et al. Is axillary reverse mapping feasible in breast cancer patients? Eur J Surg Oncol. 2015;41:442–9.

    Article  CAS  PubMed  Google Scholar 

  30. Beek MA, Gobardhan PD, Klompenhouwer EG, Menke-Pluijmers NB, Steenvoorde P, Markus JWS, et al. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer. Eur J Surg Oncol. 2020;46:59–64.

    Article  PubMed  Google Scholar 

  31. Abdelhamid MI, Bari AA, Farid MI, Nour H. Evaluation of axillary reverse mapping (ARM) in clinically axillary node negative breast cancer patients -randomised controlled trial. Int J Surg. 2020;75:174–8.

    Article  PubMed  Google Scholar 

  32. Faisal M, Sayed MG, Antonious K, Bakr AA, Farag H. Prevention of lymphedema via axillary reverse mapping for arm lymph-node preservation following breast cancer surgery: a randomized controlled trial. Patient Saf Surg. 2019;13:35. https://doi.org/10.1186/s13037-019-0217-1.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Beek MA, Gobardhan PD, Klompenhourwer ED, Rutten HJT, Voogd AC, Luiten EJT. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients. Eur J Surg Oncol. 2015;41:59–63.

    Article  CAS  PubMed  Google Scholar 

  34. Yuan Q, Wu G, Xiao SY, Hou J, Ren Y, Wang H, et al. Identification and preservation of arm lymphatic system in axillary dissection for breast cancer to reduce arm lymphedema events: a randomize clinical trial. Ann Surg Oncol. 2019;26:3446–544.

    Article  PubMed  Google Scholar 

  35. Cowher MS, Grobmyer SR, Lyons J, O’Rourke C, Baynes D, Crowe JP. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results. J Am Coll Surg. 2014;218:819–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Center, Kanazawa Medical University Hospital, Ishikawa, Japan

    Masakuni Noguchi, Masafumi Inokuchi, Miki Noguchi, Emi Morioka & Yukako Ohno

  2. Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Daigaku 1-1, Uchinada, Ishikawa, 920-0293, Japan

    Masakuni Noguchi, Masafumi Inokuchi, Miki Noguchi, Emi Morioka & Yukako Ohno

  3. Department of Breast Surgery, Nippon Medical School Hospital, Tokyo, Japan

    Tomoko Kurita

Authors
  1. Masakuni Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masafumi Inokuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miki Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emi Morioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yukako Ohno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomoko Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masakuni Noguchi.

Ethics declarations

Conflict of interest

The authors have no potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noguchi, M., Inokuchi, M., Noguchi, M. et al. Axillary surgery for breast cancer: past, present, and future. Breast Cancer 28, 9–15 (2021). https://doi.org/10.1007/s12282-020-01120-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-020-01120-0

Keywords

Search

Navigation